Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
tirzepatide source Benefits of Injections MEDVi is showing what USM Quantity:24
MEDVi is showing what a new kind of company can look like A telehealth platform selling GLP-1 weight-loss drugs directly to consumers Built in ~2 months with ~20K Now tracking toward $1.8B
Reusing needles is a false economy
USM
Quantity:24
(2026, Clinical Obesity) reviewed six studies covering 480,825 adults on GLP-1 medications and found that nutritional deficiencies are common — vitamin D deficiency hit 13.6% at 12 months, iron depletion was frequent (26–30% lower ferritin vs comparators), and B vitamin deficiencies rose steadily over treatment
